Heart Valve Technology

Alabama Medical Center First in Southeast to Offer CoreValve Evolut Pro TAVR Device
News | Heart Valve Technology | April 20, 2017

April 20, 2017 — The Structural Heart Program at Princeton Baptist Medical Center, (Birmingham, Ala.) recently...

Updated AATS Guidelines Help Cardiovascular Surgeons Navigate Challenges of Managing Ischemic Mitral Regurgitation
News | Heart Valve Technology | April 20, 2017

April 20, 2017 — Mitral regurgitation can occur in up to 50 percent of patients with ischemic heart disease and even...

PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices | April 11, 2017

April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...

Boston Scientific is buying TAVI valve maker Symetis, which has European approval for its Acurate Neo valve

The Symetis Acurate Neo TAVI valve.

News | Heart Valve Technology | April 11, 2017

April 10, 2017 — Boston Scientific recently announced a $435 cash deal to acquire Symetis SA, a privately-held Swiss...

Videos | Heart Valve Technology | March 24, 2017

Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center,...

microbleeds, brain bleeds caused by TAVR

An MRI brain scan showing multiple microbleeds in a transcatheter aortic valve replacement (TAVR) patient from the study.

Feature | Heart Valve Technology | March 23, 2017

March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic...

Cardiogard embolic protection system for surgical valve reaplacement

The CardioGard embolic protection system for surgical aortic valve replacement.

Feature | Embolic Protection Devices | March 22, 2017

March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...

Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology | March 22, 2017

March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...

RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis

A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.

Feature | Heart Valve Technology | March 21, 2017

March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood...

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

Melody transcatheter pulmonary valve, FDA expands indication, Melody for use in replacing failed surgical valves
Technology | Heart Valve Technology | March 14, 2017

March 14, 2017 — The United States Food and Drug Administration (FDA) has expanded use of the Medtronic Melody...

TAVR, TAVI, conscience sedation
Feature | Heart Valve Technology | March 14, 2017

March 14, 2017 — Transcatheter aortic valve replacement (TAVR) for aortic stenosis continues to evolve with the...

Boston Scientific Lotus TAVR valve, Lotus transcatheter aortic valve
News | Heart Valve Technology | March 09, 2017

March 9, 2017 — Boston Scientific announced the German District Court of Düsseldorf has determined that Edwards...

interventional cardiology, cath lab videos
Feature | Cath Lab | March 07, 2017

Here is a compilation of some of DAIC's recent video coverage of new interventional cardiology device technologies...

Overlay Init